Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain.
about
A comprehensive review of rapid-onset opioids for breakthrough painWhat to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert OpinionMarketed New Drug Delivery Systems for Opioid Agonists/Antagonists Administration: A Rapid OverviewRecent advances in the use of opioids for cancer painPharmacologic management of adult breakthrough cancer pain.Breakthrough pain management using fentanyl buccal tablet (FBT) in combination with around-the-clock (ATC) opioids based on the efficacy and safety of FBT, and its relationship with ATC opioids: results from an open-label, multi-center study in JapaCanadian recommendations for the management of breakthrough cancer pain.Relative Bioavailability of Fentanyl Following Various Dosing Regimens of Fentanyl Buccal Tablet in Healthy Japanese Volunteers.Extent of Fentanyl Accumulation Following Multiple Doses of Fentanyl Buccal Tablet 400 microg in Healthy Japanese Volunteers.Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant painPain management in patients with cancer: focus on opioid analgesics.Considerations in selecting rapid-onset opioids for the management of breakthrough pain.Fentanyl for the treatment of tumor-related breakthrough pain.Fentanyl buccal tablet for the treatment of breakthrough pain: pharmacokinetics of buccal mucosa delivery and clinical efficacy.A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet.Fentanyl transmucosal tablets: current status in the management of cancer-related breakthrough pain.Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial.Initial titration with 200 μg fentanyl buccal tablets: a retrospective safety analysis in Korean cancer patients.Rapid acting fentanyl formulations in breakthrough pain in cancer. Drug selection by means of the System of Objectified Judgement Analysis.Prise en charge pharmacologique de la douleur cancéreuse paroxystique chez l’adulte.
P2860
Q26862553-9417ACFF-4B29-4EAE-8FF1-8A668AA0E50CQ28069133-0DB042B2-2A9D-4A7B-AE80-08EB87816C24Q28079382-6488B87A-60CF-4E59-B559-DE709BAB5D4FQ34418203-B33E5B9F-7123-4370-A548-863DC101AEB7Q34690059-DE951E1C-FA18-4917-91F2-A6BFFE2E7141Q34775864-2BFECFDC-B550-4A06-B33B-ED570FC1C339Q36807866-51BF1E53-11A2-41E4-8478-D969808EDF25Q37412438-618AD117-22DB-46D4-8C60-06CAF8ED2A52Q37412482-5DDF3B80-5D6B-4AD9-A123-4C739BC75A0CQ37593370-729B5D69-D155-477E-B6C6-E8813CBE1562Q37863588-89E537BE-E325-4F9A-B336-EE62975CFC49Q38090468-8C91ABD7-15CF-4ACE-9AC8-B92C5E3AAA8AQ38106698-17290398-1D7C-46F2-B742-3A45CA971BAFQ39282960-EA3E3335-3EA1-49C1-9DC4-06CD7016C238Q39325643-13BCFC6E-0C90-4F47-BE1D-A02E051218A0Q42230948-C324C693-8ED4-493E-8E35-5A8D796BD763Q47803312-603EE0FC-FD7D-408E-837C-95865B5B4CCFQ48860696-232C4362-5315-4429-8D1D-8DC5062E1242Q53681112-AF0300E6-31F5-4CCF-A911-21153CC6593CQ55077608-BE4F96C1-6420-4263-B3E8-50253BC290C0
P2860
Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Fentanyl buccal tablet for rel ...... h cancer-related chronic pain.
@en
Fentanyl buccal tablet for rel ...... h cancer-related chronic pain.
@nl
type
label
Fentanyl buccal tablet for rel ...... h cancer-related chronic pain.
@en
Fentanyl buccal tablet for rel ...... h cancer-related chronic pain.
@nl
altLabel
Fentanyl buccal tablet for rel ...... th cancer-related chronic pain
@en
prefLabel
Fentanyl buccal tablet for rel ...... h cancer-related chronic pain.
@en
Fentanyl buccal tablet for rel ...... h cancer-related chronic pain.
@nl
P2093
P921
P1476
Fentanyl buccal tablet for rel ...... th cancer-related chronic pain
@en
P2093
John Messina
Neal E Slatkin
Thalia J Segal
P304
P407
P577
2007-07-01T00:00:00Z